Clinical Trials Directory

Trials / Terminated

TerminatedNCT00970541

Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome

Phase 1 Study That Will Compare 12 Weeks of Supplementation With Cinnamon Extract on the Action of Insulin and Blood Sugar (Glucose) With 12 Weeks of Supplementation With a Placebo.

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Cinnamon from the Cassae Plant is effective in the body as insulin could lower blood sugar levels.

Detailed description

Insulin resistance is a condition in which body cells do not fully respond to the action of insulin, a hormone that controls the amount of sugar (glucose) in the blood. As a result, blood sugar levels become abnormally high. Insulin resistance is common in women with polycystic ovary syndrome (PCOS). This study involves the administration of a nutritional supplement (cinnamon extract). The cinnamon extract like regular cinnamon powder comes from the bark of Cinnamon Cassae plant. It is believed that cinnamon may act in the same way as insulin and therefore could potentially improve insulin resistance and help to lower blood sugar (glucose) levels.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCinnamon Supplementation1, 3, or 6g of cinnamon per day for 40 days
DIETARY_SUPPLEMENTPlacebo (wheat flour)1, 3, or 6g of placebo per day for 40 days

Timeline

Start date
2009-08-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2009-09-02
Last updated
2021-08-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00970541. Inclusion in this directory is not an endorsement.